Vice President, Global Program Head Oncology

优缺点分析

角色解读

• This role is a top-tier executive position within the organization
• potential career progression includes moving to Senior Vice President or Head of a Therapeutic Area, or transitioning to Chief Medical Officer or Chief Development Officer roles.
• Given the high visibility and strategic impact, successful candidates often advance to broader leadership roles across the company or within the industry.
• The role provides extensive exposure to global markets and regulatory systems, positioning individuals for C-level opportunities in biopharma.
• Define and execute the global strategic vision for late-stage oncology programs, ensuring alignment across R&D, regulatory, commercial, and manufacturing functions.
• Lead cross-functional Global Program Teams (GPTs) to drive clinical development, secure regulatory approvals, and optimize market access and commercial value.
• Serve as the primary internal and external spokesperson for the program, representing the company in alliance governance and key stakeholder meetings.
• Anticipate and respond to changes in the competitive landscape, regulatory environment, and internal priorities to adapt program strategy.
• Deep expertise in oncology drug development, including late-stage clinical development and regulatory submission experience.
• Strong leadership and team management skills, with a proven ability to lead multidisciplinary global teams in a matrix organization.
• Excellent strategic thinking and business acumen, capable of balancing scientific rigor with commercial priorities.
• Outstanding communication and negotiation skills to influence internal and external stakeholders, including regulatory authorities and alliance partners.

申请策略

• Tailor your cover letter to articulate your vision for advancing oncology programs and how you align with Merck's patient-centric mission.
• Research EMD Serono's pipeline and recent approvals to demonstrate genuine interest and preparedness during interviews.
• Emphasize your track record of leading global oncology programs from late-stage development through regulatory approval and launch, highlighting specific assets and outcomes.
• Showcase your experience in building and leading cross-functional global teams, with examples of matrix management and alliance governance.
• Quantify achievements: e.g., 'Led a Phase 3 oncology program resulting in FDA approval and $X billion in peak sales.'
• Highlight any experience with global regulatory submissions (FDA, EMA, PMDA) and interactions with health authorities.
• If you lack late-stage oncology experience, consider seeking opportunities to lead a Phase 2/3 program or take on a role in regulatory strategy.
• Strengthen your understanding of commercial and market access aspects of drug development, as this role requires balancing scientific and business priorities.

面试指南

• Use the STAR method (Situation, Task, Action, Result) for behavioral questions, focusing on your strategic thinking and leadership impact.
• For strategic questions, demonstrate a structured approach: analyze the situation, identify key drivers, propose a clear plan, and explain how you would execute and communicate it.
• Show that you can balance scientific rigor with commercial feasibility
• frame answers in terms of patient value and business outcomes.
• Describe a time you had to lead a global program through a major regulatory or scientific setback. How did you adjust strategy and maintain alignment?
• How would you approach building a strategic vision for a novel oncology asset with limited data?
• Give an example of a successful alliance partnership you managed. How did you balance the interests of both parties?
• How do you ensure cross-functional teams remain aligned and motivated when facing conflicting priorities?